Skip to main content
Clinical Trials/NCT04654637
NCT04654637
Unknown
Not Applicable

Department of Nursing, Tzu Chi University, Hualien, Taiwan

Tzu Chi University1 site in 1 country128 target enrollmentNovember 1, 2020
ConditionsCancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
Tzu Chi University
Enrollment
128
Locations
1
Primary Endpoint
Frailty trend
Last Updated
5 years ago

Overview

Brief Summary

Due to the changes in lifestyle caused by the COVID-19, it is a priority to provide multi-interactive digital platforms and social media for nutrition and exercise programs for cancer patients. A two-year serial program uses mixed study methods of longitudinal combined experimental study. We will investigate cancer frailty's current situation and track the frailty trends after cancer patients received different treatments. We will also invite experts to develop multi-interactive digital platforms of nutrition and performance-based tailored circuit training programs according to the cancer frailty survey. We will recruit 20-85 years of newly diagnosed or first-time recurrence cancer patients and stratified randomization assigned to evaluate nutrition and physical exercise intervention effectiveness. The measure indicators were treatment-related adverse events, nutritional status, frailty status, survival rate, and life quality.

Registry
clinicaltrials.gov
Start Date
November 1, 2020
End Date
November 30, 2023
Last Updated
5 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chun Hou Huang

Assistance Professor

Tzu Chi University

Eligibility Criteria

Inclusion Criteria

  • Aged from 20-85 years with histological confirmation malignancy.
  • Requiring treatment by surgery, chemotherapy, hormonotherapy, radiotherapy, or targeted therapy with a curative intention as estimated by oncologists.
  • First diagnosed or recurrence of head and neck cancer, esophageal cancer, colon/rectum cancer, lung cancer, AML, ALL, lymphoma, multiple myeloma.

Exclusion Criteria

  • Non-head and neck cancer, esophageal cancer, colon/rectum cancer, lung cancer, AML, ALL, lymphoma, multiple myeloma with first diagnosis or recurrence patients.
  • Eastern Cooperative Oncology Group test score\>
  • Serious psychiatric or cognitive problems, and functional disability leading to a total inability to walk.

Outcomes

Primary Outcomes

Frailty trend

Time Frame: After treatment three-month

After treatment frailty condition

Secondary Outcomes

  • Treatment-related adverse events(After treatment one month)

Study Sites (1)

Loading locations...

Similar Trials